Genetic factors associated with prostate cancer conversion from active surveillance to treatment

MLA

Jiang, Y., et al. Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1340014287&authtype=sso&custid=ns315887.

APA

Jiang, Y., Meyers, T., Emeka, A., Cooley, L., Cooper, P., Lancki, N., Helenowski, I., Kachuri, L., Lin, D., Stanford, J., Newcomb, L., Kolb, S., Finelli, A., Fleshner, N., Komisarenko, M., Eastham, J., Ehdaie, B., Benfante, N., Logothetis, C., … Witte, J. (2022). Genetic factors associated with prostate cancer conversion from active surveillance to treatment.

Chicago

Jiang, Y, Tj Meyers, Aa Emeka, Lf Cooley, Pr Cooper, N Lancki, I Helenowski, et al. 2022. “Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1340014287&authtype=sso&custid=ns315887.